Charles River Laboratories, a Wilmington, Mass., pharma services giant, is closing a Skokie office that will result in the ...

Charles River has been riding rough waters in 2024, and as the CRO’s CEO predicted, the third quarter proved no exception. | ...

Charles River Laboratories raised its full-year profit forecast after beating analysts' estimates for quarterly results as the contract research firm expects demand to stabilize from biotech clients ...

On Nov. 8, the Boston Public Health Commission released a health advisory due to a cyanobacteria bloom in Sprague Pond in Hyde Park, which falls in the Neponset River watershed. For two weeks in ...

TD Cowen raised the firm’s price target on Charles River (CRL) to $227 from $203 and keeps a Hold rating on the shares. The firm said solid 3Q results are positive indication thhe company is nearing a ...

Have you evaluated the performance of Charles River Laboratories' (CRL) international operations for the quarter ending September 2024? Given the extensive global presence of this medical research ...

New heat pump technology under construction will pull energy out of the river and convert it to steam for heating industrial ...

WILMINGTON, Mass. — WILMINGTON, Mass. — Charles River Laboratories International Inc. (CRL) on Wednesday reported third-quarter earnings of $69.7 million. On a per-share basis, the Wilmington, ...

New York State Teachers Retirement System trimmed its stake in Charles River Laboratories International, Inc. (NYSE:CRL – ...

A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be ...

In a report released on November 7, Patrick B Donnelly from Citi maintained a Sell rating on Charles River Labs (CRL – Research Report).